Pulmonary Tuberculoses Clinical Trial
Official title:
Prevalence and Burden of Bronchiectasis in Tuberculous Patients
Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree
Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree. The prevalence of bronchiectasis is age-related and occurs in every age group and in the pre-antibiotic era . it most often began in childhood. Recent evidence shows that bronchiectasis disproportionately affects women and older individuals and will be contributing to increase in healthcare burden.[3] International data show an increase in the prevalence of bronchiectasis over recent years. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05017324 -
Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial
|
N/A | |
| Completed |
NCT04207112 -
Economic Evaluation of New MDR TB Regimens
|
Phase 2/Phase 3 | |
| Completed |
NCT04044001 -
BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT03159975 -
Safety and Immunogenicity Study of GX-70 in TB Patient
|
Phase 1 | |
| Completed |
NCT02984579 -
Line Probe Assay Evaluation Study
|
N/A | |
| Completed |
NCT05568368 -
Time-to-Detection in Culture of Mycobacterium Tuberculosis
|
||
| Recruiting |
NCT04930978 -
Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
|
||
| Not yet recruiting |
NCT05477966 -
A Retrospective Cohort Study to Develop Markers for TB Severity and Treatment Progress
|
||
| Completed |
NCT05097638 -
Lung Health After Tuberculosis: Clinical and Functional Assessment in Post Pulmonary Tuberculosis Egyptian Patients.
|
||
| Active, not recruiting |
NCT05045391 -
Pulmonary Aspergillosis in Tuberculosis Patients
|
||
| Completed |
NCT02754765 -
Evaluating Newly Approved Drugs for Multidrug-resistant TB
|
Phase 3 | |
| Active, not recruiting |
NCT03896685 -
Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)
|
Phase 3 |